There are two known susceptibility loci for NAFLD (SAMM50, PNPLA3) and three potentially new candidate genetic regions for a clinical NAFLD diagnosis (APOE, SUGP1, TRIB1) (20). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.